Annotation Detail for FAIM2
Basic Information
Top
Pathway ID | Pathway Name |
---|
200067 | FAS (CD95) signaling pathway |
Desease Name |
---|
Body mass index |
weight |
METABOLIC |
waist circumference |
Desease Name |
---|
Waist circumference |
Body mass index |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of FAIM2 mRNA | decreases expression | 20406850
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FAIM2 mRNA | affects expression | 16483693
|
D019207 |
beta Carotene |
beta Carotene results in increased expression of FAIM2 mRNA | increases expression | 17034753
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of FAIM2 mRNA | increases expression | 17412507
|
C116926 |
rofecoxib |
rofecoxib results in decreased expression of FAIM2 mRNA | decreases expression | 17070997
|
C025643 |
vinclozolin |
vinclozolin affects the expression of FAIM2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
3.18 | 15113128 15688392 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.89 | 19015723 |
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
4.52 | 16690336 |
MESH:D002545 |
Brain Ischemia |
|
beta Carotene |
5.55 | 16157235 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
3.13 | 11306469 16253758 14633655 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.78 | 16705839 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
4.15 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.74 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
7.74 | 7505956 2727394 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
3.34 | 12902858 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.72 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.44 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
2.04 | 21346803 18551238 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
5.16 | 15652904 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
5.69 | 11555667 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.40 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.82 | 16417039 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
3.66 | 9825942 |
MESH:D015658 |
HIV Infections |
|
beta Carotene |
4.19 | 16960176 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
7.81 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.81 | 16467254 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
5.45 | 15831440 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.72 | 11245490 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.24 | 16705839 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.19 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
4.42 | 15526292 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
3.08 | 17565644 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.24 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
7.01 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta Carotene |
7.01 | 17113696 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.88 | 16080182 |
MESH:D008175 |
Lung Neoplasms |
|
beta Carotene |
3.33 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
3.33 | 18062963 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
4.23 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
5.12 | 14633661 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
3.77 | 19196723 16619500 17020996 10767621 10838139 15313902 16944150 11751437 16051031 15688392 14633655 15113128 12931682 17131329 16827153 14999141 11807958 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.32 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
beta Carotene |
6.32 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
6.32 | 15533788 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
4.89 | 12696579 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.95 | 11555667 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.74 | 16049721 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
4.55 | 16690336 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
5.91 | 16678543 18165598 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
3.45 | 16965848 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.36 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.40 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
4.06 | 15682402 12376480 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.40 | 18629315 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
4.64 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.95 | 11555667 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.74 | 18551238 |
MESH:D013272 |
Stomach Diseases |
|
beta Carotene |
5.55 | 17638125 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
2.70 | 15930296 16257854 18593901 |
MESH:D013276 |
Stomach Ulcer |
|
beta Carotene |
4.58 | 12500499 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
5.69 | 11418001 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
4.16 | 7505956 3078959 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.39 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 10091137 |